Slocum, Gordon & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Slocum, Gordon & Co's MRK Position: Q3 2026 in Review
Slocum, Gordon & Co reduced its Merck (MRK) stake by 1.6% in Q3 2026, selling an estimated $206K and leaving 91,691 shares worth $13.3M. The position accounts for 9.3% of the portfolio, ranked #1.
Slocum, Gordon & Co first reported a position in MRK in Q4 2022 and has held it in 16 quarters since. The position peaked at $14.5M in Q4 2022. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Slocum, Gordon & Co held 91,691 shares of Merck worth $13.3M as of Q3 2026.
- Slocum, Gordon & Co sold 1,490 Merck shares in Q3 2026, an estimated $206K.
- Merck made up 9.3% of Slocum, Gordon & Co's portfolio in Q3 2026, its #1 holding.
- Slocum, Gordon & Co first reported a position in Merck in Q4 2022 and has held it in 16 quarters since.
- Slocum, Gordon & Co's Merck position peaked at $14.5M in Q4 2022.
- 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Slocum, Gordon & Co's 13F filing for Q3 2026, filed 19 Oct 2026.